Clene Inc. (CLNN) Stock Price & Analysis

Clene Inc. (CLNN) rose 0.00% to USD 5.39 as of July 26, 2026 at 12:47 UTC, according to Nexqual real-time market data.

CLNN last closed at USD 5.39; the session ranged USD 5.31–5.5 on volume of 48,182 shares. Market capitalization is —, with a 52-week range of USD 3.25–13.5 (NCM). Source: Nexqual, July 26, 2026 at 12:47 UTC.

Key Statistics (as of July 26, 2026 at 12:47 UTC)

Technical Analysis (CLNN)

Nexqual's technical model rates CLNN "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 12:47 UTC.

From Clene Inc.'s Latest SEC 10-K Filing (filed 2026-03-17)

Key Strengths & Strategy (as disclosed to the SEC)

• These include:       Our CSN  Therapeutics Platform   By uniting concepts from electrochemistry, nanotechnology, plasma and quantum physics, materials science, and biochemistry, we have created and refined a proprietary electrocrystallization method that results in single component or multiple component nanocrystals of the transition elements that are clean-surfaced, highly faceted, and biologically catalytically active (see Figure 1 for example nanocrystals).
• The HEALEY ALS Platform Trial is the first platform trial for ALS and is intended to accelerate the development of ALS therapies by simultaneously testing multiple therapeutics under a master protocol, in order to reduce costs, decrease trial time, and increase patient participation.
• The new analysis incorporated up to 42 months (3.5 years) of survival follow-up and 76 weeks of long-term NfL biomarker results, including an NfL responder subset (the "CNM-Au8 NfL Responders") from the HEALEY ALS Platform Trial who had consistent and sustained NfL reductions, comprising nearly half of all CNM-Au8 patients.
• To our knowledge, we believe we are the only company currently developing catalytically-active nanocrystals to directly modulate biological systems as therapeutic drug candidates.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 12:47 UTC. This page is informational and not investment advice.